# Strategic Feedback — GPT-5.4 (R2)

**Role:** Journal editor (AER perspective)
**Model:** openai/gpt-5.4
**Timestamp:** 2026-04-01T10:50:34.332124
**Route:** OpenRouter + LaTeX
**Tokens:** 8996 in / 3752 out
**Response SHA256:** fc725134bed95845

---

## 1. THE ELEVATOR PITCH

This paper asks a simple, policy-relevant question: when states add doula services as a covered Medicaid benefit, do birth outcomes improve at the population level? Using recent staggered adoption across eight states and nationwide birth records, the paper finds that Medicaid doula reimbursement had essentially no detectable short-run effect on C-sections or related birth outcomes, suggesting a sharp gap between the efficacy of doula support for users and the effectiveness of coverage expansion as policy.

A busy economist should care because this is not really a paper about doulas; it is a paper about a broader policy problem: why insurance coverage expansions often fail to translate into actual care and measurable health gains.

**Does the paper articulate this clearly in the first two paragraphs?**  
Mostly yes, but not optimally. The current opening is competent and policy-aware, but it spends too much time on maternal health background and not enough time immediately defining the core economic question: why do interventions with strong individual-level evidence so often disappoint when scaled through public insurance? The paper’s best idea is the efficacy-to-policy translation problem; that should appear on line 1, not line 12.

**What the first two paragraphs should say instead:**

> Many health policies are built on a simple inference: if a service improves outcomes for users, making that service covered by insurance should improve outcomes in the population. But that inference often fails because coverage is not care. Take-up, provider supply, billing frictions, and patient awareness can all sever the link between financing and delivery.
>
> This paper studies that disconnect in the context of Medicaid doula reimbursement. Doulas are widely cited as a promising way to reduce cesarean delivery and improve maternal health, and states have rapidly expanded Medicaid coverage of doula services. Using staggered adoption across eight states and national birth records, I ask whether adding doulas to Medicaid benefits changes birth outcomes at the population level. The answer is essentially no in the short run, implying that coverage expansions without delivery infrastructure may have little effect even when the underlying service is beneficial.

That is the AER pitch. The current version is close, but still sounds a bit like “important topic + credible design + null effect.” It needs to sound like “general lesson about how policy works.”

---

## 2. CONTRIBUTION CLARITY

**Contribution in one sentence:**  
The paper shows that covering doula services in Medicaid does not, in the short run, measurably improve population birth outcomes, highlighting a broader disconnect between insurance coverage expansions and realized care delivery.

### Is this contribution clearly differentiated from the closest 3-4 papers?
Partially, but not sharply enough. Right now the paper differentiates itself mainly by saying: prior studies estimate effects of *using* doulas, while this paper estimates the effect of *covering* doulas. That is a real distinction, but it is still narrower than it should be. The introduction needs to make clearer that the paper is not just the first DiD on doula reimbursement; it is testing whether financing policy can reproduce individual-level treatment effects at scale.

The danger at present is that the contribution reads as:
- “first paper on Medicaid doula reimbursement using staggered DiD,” rather than
- “evidence on when public coverage expansions fail to translate clinical efficacy into population impact.”

That distinction matters enormously for placement.

### Is the contribution framed as answering a question about the WORLD, or filling a gap in a LITERATURE?
It is mixed, but better when it talks about the world. The strongest parts ask: what happens when a state flips the reimbursement switch? The weaker parts sound like: no one has estimated this policy variation yet. The former is stronger. AER papers answer questions about the world.

### Could a smart economist who reads the introduction explain to a colleague what's new?
Yes, but only if they are sympathetic. They would probably say: “It’s a paper on Medicaid doula reimbursement showing a null average effect despite strong prior evidence on doulas.” That is decent. But they might also say: “It’s another staggered-adoption reduced-form paper in health policy with a null.” That is the risk.

The introduction currently gives the reader the ingredients for the strong version, but not quite the conviction.

### What would make this contribution bigger?
Several possibilities:

1. **Make take-up the center of gravity.**  
   The paper’s most interesting implied mechanism is low utilization / weak pass-through from coverage to care. Right now take-up is inferred, not measured. If the author can bring in state-level claims data, enrollment counts, doula certification counts, billing volumes, or even descriptive implementation metrics, the paper gets much bigger. The general claim becomes demonstrated rather than conjectured.

2. **Exploit heterogeneity in implementation intensity.**  
   Reimbursement rates vary dramatically. States differ in certification burdens, launch timing, managed care integration, and provider networks. If the null is concentrated in low-reimbursement / high-friction states, the paper becomes about policy design, not just average effect.

3. **Broaden the substantive implication beyond C-sections.**  
   The current additional outcomes are conventional but not especially revealing. If there are measures closer to what doulas plausibly affect—labor interventions, induction, epidural use, VBAC, maternal morbidity, breastfeeding initiation, NICU use, patient experience—those could sharpen the story. Right now the outcome set is serviceable, but not yet expansive enough to carry a top-journal policy lesson.

4. **Connect more explicitly to implementation economics.**  
   The paper wants to coin “coverage-to-care gap,” but the concept needs either stronger theorization or stronger empirical grounding to feel bigger than branding. A simple framework—policy coverage × provider supply × patient take-up × hospital receptivity—would help.

The single biggest way to enlarge the contribution is not more specifications; it is **direct evidence on why coverage did not become care**.

---

## 3. LITERATURE POSITIONING

### Closest neighbors
The nearest literatures seem to be:

1. **Clinical / observational doula literature**
   - Bohren et al. (Cochrane review on continuous labor support)
   - Kozhimannil et al. (Medicaid / doula use and C-sections)
   - Hodnett et al. / continuous support literature

2. **Health insurance and utilization / pass-through literature**
   - Oregon Health Insurance Experiment papers (Finkelstein et al.)
   - Wherry / Dave / post-ACA Medicaid utilization work
   - Broader work on parity mandates and why coverage expansions do or do not change use

3. **Maternal health economics**
   - Howell on racial disparities in obstetric care
   - Medicaid financing of births / perinatal care
   - Papers on hospital obstetric practice variation and C-section rates

4. **Implementation / provider supply**
   - Medicaid reimbursement and provider participation
   - Network adequacy / physician participation in Medicaid
   - Supply responses to public insurance policy

### How should the paper position itself relative to those neighbors?
**Build on the doula efficacy literature, but pivot quickly away from it.**  
The paper should not “attack” the RCT/clinical literature. It should say: those papers answer whether doulas help users; I ask whether insurance coverage scales that benefit. That is complementary, not adversarial.

**Build more directly on insurance take-up and provider participation papers.**  
That is where the paper’s economics identity lies. The most natural positioning is: this is a maternal-health application of a general implementation problem in publicly financed care.

**Potentially synthesize two conversations:**  
- clinical efficacy of nonmedical labor support  
- economics of incomplete pass-through from insurance coverage to service use

That synthesis is the paper’s comparative advantage.

### Is the paper currently positioned too narrowly or too broadly?
Right now it is positioned **too narrowly in topic and too broadly in aspiration**.

- Too narrowly because it sounds very “doula policy” for stretches.
- Too broadly because “coverage-to-care gap” is asserted as a general concept without enough engagement with adjacent literatures that have studied similar frictions under other names.

The paper should narrow its claims and broaden its conversation.

### What literature does the paper seem unaware of?
It needs deeper engagement with:
- provider participation in Medicaid and reimbursement pass-through
- implementation failures in health policy
- insurance expansions that changed coverage more than utilization
- hospital production / obstetric practice style / medicalization of birth
- potentially street-level bureaucracy / administrative burden if certification and billing matter

Right now it cites some coverage-expansion papers, but the discussion remains somewhat thin. The author needs to show that this paper belongs not only in maternal health, but in a broader economics conversation about why financing reforms underperform.

### Is the paper having the right conversation?
Not quite yet. It is having a decent conversation with maternal-health and DiD readers. It should instead have a sharper conversation with economists interested in **when public insurance expansions do not translate into real services**. That is the more surprising and general frame.

---

## 4. NARRATIVE ARC

### Setup
There is strong evidence that doula support improves individual birth outcomes, especially reducing C-sections. States have therefore expanded Medicaid coverage of doula services, apparently expecting those individual benefits to scale.

### Tension
But the mechanism from coverage to outcomes is not automatic. Coverage may not generate use if there are too few doulas, reimbursement is too low, certification is cumbersome, patients are unaware, or hospitals do not integrate doulas well. So the key puzzle is whether financing a beneficial service through Medicaid actually changes population outcomes.

### Resolution
In the short run, it does not: the average effect on C-sections and related outcomes is near zero.

### Implications
The results suggest that public insurance coverage alone may be insufficient to deliver effective care at scale. Policymakers should pair coverage expansions with workforce and implementation investments; researchers should be cautious about extrapolating from treatment efficacy to policy effectiveness.

### Does the paper have a clear narrative arc?
**Yes, but only in embryo.** The ingredients are all present, but the paper still often reads like a collection of estimates around a null main effect. The event study, placebo, DDD, race gap, and robustness all accumulate, but the story is not yet disciplined enough.

There is also a tonal issue: the paper occasionally seems overly eager to defend the null (“this near-null is not a failure of the research design”) instead of advancing the positive argument. A stronger paper would say: “The null *is* the finding, because it reveals the missing margin between insurance coverage and care delivery.”

### If it is a collection of results looking for a story, what story should it tell?
It should tell one story only:

**States are trying to scale a clinically promising service through Medicaid. The service may work; the policy, in the short run, does not. The reason is that insurance coverage is only one input into effective care delivery.**

Everything should serve that story:
- main result: no population effect
- placebo: not a generic state-level confound
- race result: disparities persist despite coverage
- reimbursement variation / supply constraints: likely explanation
- broader implication: coverage expansion without delivery capacity will disappoint

The event-study and methodological detail should support, not dominate.

---

## 5. THE "SO WHAT?" TEST

### What fact would I lead with?
“States rapidly added doula services to Medicaid because prior evidence suggested large benefits—but when you look at 17 million births, adding the benefit had basically no detectable short-run effect on C-sections.”

That is a good opening fact.

### Would people lean in or reach for their phones?
Economists would **lean in initially**, because the contrast between large individual effects and near-zero policy effects is intrinsically interesting. But they will only stay engaged if the author can answer the obvious follow-up:

### What follow-up question would they ask?
“Why not?”

And that is where the paper is currently vulnerable. It has a plausible answer—low take-up, supply bottlenecks, implementation frictions—but little direct evidence. So the paper passes the first “so what?” test and stumbles on the second.

### If the findings are null or modest: is the null itself interesting?
Yes, potentially very interesting. It is not a failed experiment if the paper frames it correctly. The null is informative because:
- the prior literature and policy rhetoric implied large gains,
- states are actively adopting the policy,
- maternal health is salient,
- the null reveals a gap between financing reform and service delivery.

But to make the null feel important rather than merely disappointing, the paper must convince readers that it has learned something about policy translation, not just that one intervention didn’t move in a short window.

Right now it is about 70% of the way there.

---

## 6. STRUCTURAL SUGGESTIONS

### What would make it read better?

1. **Shorten the policy background substantially.**  
   It is fine, but too much of it is descriptive and unsurprising. Compress to one page. Move reimbursement-rate detail and state implementation timing to an appendix or concise table.

2. **Move the general concept up front and simplify the mechanics.**  
   The introduction should not spend much real estate on estimator branding. “Using staggered policy adoption across states and national birth records” is enough in the first few paragraphs. The specific estimator citations can come later.

3. **Front-load the main finding earlier and more starkly.**  
   The paper does this reasonably well already, but it can be even punchier. The interesting contrast is not just “estimate near zero”; it is “one-fiftieth of what naïve extrapolation from user-level evidence would predict.” That line belongs very early.

4. **Trim defensive methodology prose from the introduction.**  
   Paragraph 5 (“This near-null is not a failure of the research design…”) feels like a referee response embedded in the intro. That material belongs later. In the intro, it disrupts the narrative.

5. **Integrate the race section more strategically.**  
   As currently presented, the racial disparities section feels bolted on. Either make equity one of the paper’s central motivating questions from the start, or demote this result. Right now it reads as an expected auxiliary null.

6. **The appendix on standardized effect sizes should be cut or buried.**  
   It adds no strategic value and may actually distract. Labeling tiny, imprecise estimates as “Large negative” because of scaling conventions is not helpful and may confuse readers. For AER positioning, this is clutter.

7. **The conclusion should do more than summarize.**  
   It should end with a sharper general lesson:
   - when should we expect coverage expansions to work?
   - what complementary institutions are needed?
   - what does this imply for current state policy design?

### Are there results buried in robustness that should be in the main results?
Yes: if there is any evidence on reimbursement generosity, launch timing, certification burden, or take-up, that belongs in the main text, not robustness or discussion. The paper needs more implementation substance in the main narrative.

### Is the reader forced to wade too long before learning something interesting?
No, less so than many papers. The main finding appears early. The issue is not slowness; it is that the interesting idea arrives before being fully elevated into the paper’s organizing principle.

---

## 7. WHAT WOULD MAKE THIS AN AER PAPER?

Be blunt: in current form, this is **not yet an AER paper**. It is a competent, timely health-policy paper with a potentially important result. The distance comes from three issues.

### 1. Framing problem
This is the biggest one. The paper’s true contribution is broader than “doula reimbursement has no detectable effect.” It is about the limits of insurance coverage as a policy lever when delivery capacity is missing. That should be the centerpiece.

### 2. Scope problem
The paper establishes an average short-run null, but it does not yet explain enough. For AER, readers will want to know under what conditions the policy should work, not just that the average effect is near zero. The mechanism discussion is plausible but under-evidenced.

### 3. Ambition problem
The paper is careful and sensible, but still feels a bit safe. It applies a modern policy-evaluation toolkit to a new setting and documents a null. That can be publishable, but top-field attention requires either:
- a bigger conceptual payoff, or
- richer evidence on the mechanism generating the null.

### Is it a novelty problem?
Somewhat, but less than the others. The topic is new enough. The problem is not that the question has already been answered; it is that the answer, as currently packaged, feels narrower than it could.

### What is the single most impactful piece of advice?
**Turn this from a paper about doulas into a paper about why coverage expansions fail without delivery capacity—and support that claim with direct implementation evidence, not just conjecture.**

If the author can only change one thing, that is it.

Concretely, I would urge the author to add a serious empirical section on implementation intensity: take-up, claims, doula workforce size, reimbursement rates, certification barriers, managed care rollout, or any observable measure of whether the policy actually changed access. Without that, “coverage-to-care gap” risks sounding like a label attached to a null. With it, the paper could become a meaningful contribution to health economics and public economics.

---

### Strategic Assessment

- **Current framing quality:** Adequate
- **Contribution clarity:** Somewhat fuzzy
- **Literature positioning:** Could be stronger
- **Narrative arc:** Serviceable
- **AER distance:** Medium-Far
- **Single biggest improvement:** Reframe the paper as evidence on the failure of coverage expansions without delivery capacity, and bring direct evidence on implementation/take-up to make that claim credible.